↓ Skip to main content

Bexarotene: a promising anticancer agent

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, September 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

patent
2 patents
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
62 Dimensions

Readers on

mendeley
44 Mendeley
Title
Bexarotene: a promising anticancer agent
Published in
Cancer Chemotherapy and Pharmacology, September 2009
DOI 10.1007/s00280-009-1140-4
Pubmed ID
Authors

Liyan Qu, Xiuwen Tang

Abstract

Retinoids are biologically active derivatives of vitamin A, which play essential roles in embryonic or adult cell behavior modulating cell proliferation, differentiation and apoptosis. The biologic effects of retinoids are mediated by two distinct families of intracellular receptors: retinoid acid receptors (RARs)-α, -β and -γ and retinoid X receptors (RXR)-α, -β and -γ. Bexarotene is a selective RXR agonist, which exerts its effects in blocking cell cycle progression, inducing apoptosis and differentiation, preventing multidrug resistance, and inhibiting angiogenesis and metastasis, making it a promising chemopreventive agent against cancer.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 5%
Unknown 42 95%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 20%
Researcher 8 18%
Student > Bachelor 6 14%
Professor > Associate Professor 3 7%
Student > Master 3 7%
Other 7 16%
Unknown 8 18%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 8 18%
Agricultural and Biological Sciences 7 16%
Medicine and Dentistry 6 14%
Pharmacology, Toxicology and Pharmaceutical Science 5 11%
Chemistry 3 7%
Other 7 16%
Unknown 8 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 August 2019.
All research outputs
#4,972,158
of 23,815,455 outputs
Outputs from Cancer Chemotherapy and Pharmacology
#244
of 2,501 outputs
Outputs of similar age
#19,084
of 95,263 outputs
Outputs of similar age from Cancer Chemotherapy and Pharmacology
#1
of 22 outputs
Altmetric has tracked 23,815,455 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,501 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,263 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.